Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Qingdao 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Affiliated Hospital of Qingdao University32 Tianjin Medical University17 Qilu Hospital of Shandong University8 Qingdao Central Hospital6 Alexion Pharmaceuticals, Inc.3 Jiangsu Hansoh Pharmaceutical Co., Ltd.3 Shandong University3 Ruijin Hospital3 Actelion2 Sanofi2 The First Affiliated Hospital with Nanjing Medical University2 Tianjin Medical University Cancer Institute and Hospital2 AbbVie2 Hoffmann-La Roche2 Peking University First Hospital2 BeOne Medicines2 Shanghai Chest Hospital2 Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2 Beijing Tsinghua Chang Gung Hospital2 China National Center for Cardiovascular Diseases2 AstraZeneca2 China-Japan Friendship Hospital2 Xijing Hospital1 Harbin Medical University1 Central China Fuwai Hospital of Zhengzhou University1 Peking University Third Hospital1 Inmunotek S.L.1 Beijing Friendship Hospital1 Takeda1 Shanghai Jiaolian Drug Research and Development Co., Ltd1 Chongqing Peg-Bio Biopharm Co., Ltd.1 Chunshui He1 Peking University People's Hospital1 Nanjing Leads Biolabs Co.,Ltd1 Qilu Pharmaceutical Co., Ltd.1 The First Affiliated Hospital of Dalian Medical University1 GlaxoSmithKline1 Hangzhou DAC Biotechnology Co., Ltd.1 Peking University International Hospital1 Daiichi Sankyo1 Haitao Niu, MD1 Ton-Bridge Medical Tech. Co., Ltd1 Third Military Medical University1 Chinese Academy of Sciences1 BioRay Pharmaceutical Co., Ltd.1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Bambusa Therapeutics1 Kai Huang1 Peking University1 wanghaibo1 Cloudbreak Therapeutics, LLC1 Bristol-Myers Squibb1 Stryker Neurovascular1 yu li，MD1 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Tang-Du Hospital1 Tongji Hospital1 Shanghai Changzheng Hospital1 Zhejiang Cancer Hospital1 Amgen1 Anhui Provincial Hospital1 Nanjing Medical University1 Eli Lilly and Company1 Boston Scientific Corporation1 Jin Lu, MD1 Zichao Zhang1 Second Affiliated Hospital of Guangxi Medical University1 Eye & ENT Hospital of Fudan University1 Fujian Shengdi Pharmaceutical Co., Ltd.1 Resonova (Shanghai) Medtech Limited1 Chinese University of Hong Kong1 National Research Institute for Family Planning, China1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 Antengene Biologics Limited1 Shanghai Jiao Tong University School of Medicine1 Celgene1 Zhejiang Provincial People's Hospital1 wangdongsheng1 The Hong Kong Polytechnic University1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 Innovent Biologics (Suzhou) Co. Ltd.1 Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences1 B. Braun Medical International Trading Company Ltd.1 Sichuan Baili Pharmaceutical Co., Ltd.1 Shanghai Zhongshan Hospital1 Jiangsu Simcere Pharmaceutical Co., Ltd.1 Suzhou Forlong Biotechnology Co., Ltd1 Clear sponsor filter
Site location
Qingdao1
All 1 locations
Target enrolment
to

Trials with a site in Qingdao

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
MRI Assessment of Pancreatic Fat Changes and Islet Function Recovery After Bariatric Surgery in Obese Patients
NCT07464223Obesity & Overweight, Type 2 Diabetes Mellitus (T2DM), Pancreatic Steatosis, Insulin Resistance
yu li，MD
Observational
50
Qingdao
2024-09-01
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Qingdao that also match the filters currently applied.

How many clinical trials are recruiting in Qingdao?

0 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 1 studies
PhaseStudiesRecruitingShare
Observational10100%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
yu li，MD10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.